Avanos agrees to all-cash acquisition at $25.00 per share
The acquisition price of $25.00 per share significantly exceeds market value, driving investor confidence and interest.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The acquisition price of $25.00 per share significantly exceeds market value, driving investor confidence and interest.
What happened, with direct paths to the underlying reporting
Avanos Medical, Inc. has entered a definitive agreement to be acquired by American Industrial Partners in an all-cash deal valued at $1.272 billion. The acquisition, offering significant premiums to current stock prices, is expected to close in the second half of 2026, marking a transition to a private company.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.